SPY318.63+7.27 2.33%
DIA271.01+7.68 2.92%
IXIC9,788.09+172.27 1.79%

Exagen Q1 EPS $(0.440) Beats $(0.490) Estimate, Sales $9.584M Beat $7.730M Estimate

Exagen (NASDAQ:XGN) reported quarterly losses of $(0.440) per share which beat the analyst consensus estimate of $(0.490) by 10.2 percent. The company reported quarterly sales of $9.584 million which beat the analyst

Benzinga · 05/11/2020 20:20

Exagen (NASDAQ:XGN) reported quarterly losses of $(0.440) per share which beat the analyst consensus estimate of $(0.490) by 10.2 percent. The company reported quarterly sales of $9.584 million which beat the analyst consensus estimate of $7.730 million by 23.98 percent. This is a 3.50 percent increase over sales of $9.260 million the same period last year.